In addition, the significance of developing tailored treatment strategies for ALT-positive neuroblastomas cannot be overstressed, given their unique attributes as slow-proliferating tumors inherently resistant to conventional high-risk neuroblastoma treatments. This evidence concerns the gene GPT and neuroblastoma.